80% of skeletal metastases derive from breast, prostate, lung, kidney and thyroid tumours.

The most affected sites are the vertebral column, pelvis, skull, femur and the humerus. In 75% of cases bone metastases are responsible for a variety of complications called related skeletal events (SRE) which worsen the patient's quality of life.

Electrochemotherapy of bone metastases can slow or block the growth of metastatic cells and can control pain. 

We would advise you to consult your doctor to find out if electrochemotherapy can help you.

The technology used for the treatment of bone metastases is Cliniporator® VITAE.

Please write to to find out which hospital is closest to you.

The contents of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice because of something you have read on this website.
This website does not recommend or endorse any specific tests, physicians, medical products, procedures, opinions, or other information that may be mentioned on the Site.
The site and its contents are provided on an "as is" basis by the public communication department of IGEA S.p.A.

IGEA © 2020